Search

everythinglearnresearchcommunity

for

Search:↓

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Researchers developed a 3D skin model with its own immune and blood vessel cells to better understand skin health and disease.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

c-Kit is important for heart regeneration and cancer development.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

ABCG2 protein marks stem-like skin cells in human epidermis.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Targeting the AhR pathway may help treat alopecia areata.

Human thymus has stem cells that can self-renew and maintain their identity.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

The treatments stopped hair regrowth in mice.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Potential therapeutic targets for scarring hair loss are identified.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

HPV8 causes skin cancer by expanding specific skin stem cells.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.